BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33630477)

  • 1. Time to Cannulation after ICU Admission Increases Mortality for Patients Requiring Veno-venous ECMO for COVID-19 Associated Acute Respiratory Distress Syndrome.
    Raff LA; Gallaher JR; Johnson D; Raff EJ; Charles AG; Reid TS
    Ann Surg; 2022 Dec; 276(6):e659-e663. PubMed ID: 33630477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid-19 or influenza: A single-center registry study.
    Jäckel M; Rilinger J; Lang CN; Zotzmann V; Kaier K; Stachon P; Biever PM; Wengenmayer T; Duerschmied D; Bode C; Staudacher DL; Supady A
    Artif Organs; 2021 Jun; 45(6):593-601. PubMed ID: 33188714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS.
    Raff LA; Reid TD; Johnson D; Raff EJ; Schneider AB; Charles AG; Gallaher JR
    Am J Surg; 2022 Feb; 223(2):388-394. PubMed ID: 33894980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Veno-Venous Extracorporeal Membrane Oxygenation for COVID-19 Compared to Non-COVID Etiologies.
    Ruhi-Williams P; Wu B; Nahmias J; Sagebin F; Fazl Alizadeh R; Gadde KM; Amin A; Nguyen NT
    Ann Surg; 2023 Sep; 278(3):464-470. PubMed ID: 37325899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry.
    Hayanga JWA; Song T; Durham L; Garrison L; Smith D; Molnar Z; Scheier J; Deliargyris EN; Moazami N
    Crit Care; 2023 Jun; 27(1):243. PubMed ID: 37337243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Versus Influenza-associated Acute Respiratory Distress Syndrome Requiring Veno-venous Extracorporeal Membrane Oxygenation Support.
    Cousin N; Bourel C; Carpentier D; Goutay J; Mugnier A; Labreuche J; Godeau E; Clavier T; Grange S; Tamion F; Durand A; Moussa MD; Duburcq T;
    ASAIO J; 2021 Feb; 67(2):125-131. PubMed ID: 33060407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of COVID-19 Patients With Acute Respiratory Distress Syndrome Managed With Extracorporeal Membrane Oxygenation at US Academic Centers.
    Nguyen NT; Sullivan B; Sagebin F; Hohmann SF; Amin A; Nahmias J
    Ann Surg; 2021 Jul; 274(1):40-44. PubMed ID: 33843791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Earlier Cannulation With Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients With Acute Respiratory Distress Syndrome Decrease Duration of Artificial Mechanical Ventilation?
    Hartner C; Ochsenreither J; Miller K; Weiss M
    J Dr Nurs Pract; 2020 Jul; 13(2):148-155. PubMed ID: 32817504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal Membrane Oxygenation with Right Ventricular Assist Device for COVID-19 ARDS.
    Cain MT; Smith NJ; Barash M; Simpson P; Durham LA; Makker H; Roberts C; Falcucci O; Wang D; Walker R; Ahmed G; Brown SA; Nanchal RS; Joyce DL
    J Surg Res; 2021 Aug; 264():81-89. PubMed ID: 33789179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report.
    Sawada K; Kawaji T; Yamana K; Matsuhashi K; Hara Y; Kuriyama N; Nakamura T; Maekawa A; Takagi Y; Nishida O
    J Cardiothorac Surg; 2024 Jun; 19(1):358. PubMed ID: 38915030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bloodstream and respiratory coinfections in patients with COVID-19 on ECMO.
    Shih E; Michael DiMaio J; Squiers JJ; Banwait JK; Kussman HM; Meyers DP; Meidan TG; Sheasby J; George TJ
    J Card Surg; 2022 Nov; 37(11):3609-3618. PubMed ID: 36073136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics and outcome of 70 ventilated COVID-19 patients : Summary after the first wave at a university center].
    Schroeder I; Scharf C; Zoller M; Wassilowsky D; Frank S; Stecher SS; Stemmler J; Kneidinger N; Peterß S; Zwißler B; Irlbeck M
    Anaesthesist; 2021 Jul; 70(7):573-581. PubMed ID: 33369696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent Right Ventricle Dilatation in SARS-CoV-2-Related Acute Respiratory Distress Syndrome on Extracorporeal Membrane Oxygenation Support.
    Lazzeri C; Bonizzoli M; Batacchi S; Cianchi G; Franci N; Socci F; Peris A
    J Cardiothorac Vasc Anesth; 2022 Jul; 36(7):1956-1961. PubMed ID: 34538743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Venovenous Extracorporeal Membrane Oxygenation in COVID-19 Infection: One Region's Comprehensive Experience.
    Bergman ZR; Wothe JK; Alwan FS; Dunn A; Lusczek ER; Lofrano AE; Tointon KM; Doucette M; Bohman JK; Saavedra-Romero R; Prekker ME; Brunsvold ME
    ASAIO J; 2021 May; 67(5):503-510. PubMed ID: 33492851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors of Mortality for Patients Receiving Venovenous Extracorporeal Membrane Oxygenation for COVID-19 Acute Respiratory Distress Syndrome.
    Bergman ZR; Wothe JK; Alwan FS; Lofrano AE; Tointon KM; Doucette M; Bohman JK; Saavedra-Romero R; Prekker ME; Lusczek ER; Beilman G; Brunsvold ME
    Surg Infect (Larchmt); 2021 Dec; 22(10):1086-1092. PubMed ID: 34494893
    [No Abstract]   [Full Text] [Related]  

  • 16. Same but Different-ECMO in COVID-19 and ARDS of Other Etiologies. Comparison of Survival Outcomes and Management in Different ARDS Groups.
    Golicnik A; Zivanovic I; Gorjup V; Berden J
    J Intensive Care Med; 2023 Jul; 38(7):635-642. PubMed ID: 36803290
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes of Extracorporeal Membrane Oxygenation in Patients With Severe Acute Respiratory Distress Syndrome Caused by COVID-19 Versus Influenza.
    Shih E; Squiers JJ; DiMaio JM; George T; Banwait J; Monday K; Blough B; Meyer D; Schwartz GS
    Ann Thorac Surg; 2022 May; 113(5):1445-1451. PubMed ID: 34139189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality Risk Assessment in COVID-19 Venovenous Extracorporeal Membrane Oxygenation.
    Tabatabai A; Ghneim MH; Kaczorowski DJ; Shah A; Dave S; Haase DJ; Vesselinov R; Deatrick KB; Rabin J; Rabinowitz RP; Galvagno S; O'Connor JV; Menaker J; Herr DL; Gammie JS; Scalea TM; Madathil RJ
    Ann Thorac Surg; 2021 Dec; 112(6):1983-1989. PubMed ID: 33485917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 outcomes of venovenous extracorporeal membrane oxygenation for acute respiratory failure vs historical cohort of non-COVID-19 viral infections.
    Dave SB; Rabinowitz R; Shah A; Tabatabai A; Galvagno SM; Mazzeffi MA; Rector R; Kaczorowski DJ; Scalea TM; Menaker J
    Perfusion; 2023 Sep; 38(6):1165-1173. PubMed ID: 35653427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.
    Schmidt M; Hajage D; Lebreton G; Monsel A; Voiriot G; Levy D; Baron E; Beurton A; Chommeloux J; Meng P; Nemlaghi S; Bay P; Leprince P; Demoule A; Guidet B; Constantin JM; Fartoukh M; Dres M; Combes A; ;
    Lancet Respir Med; 2020 Nov; 8(11):1121-1131. PubMed ID: 32798468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.